Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B
Clinical trial NCT03995784 · COMPLETED
Trial details
- NCT number
- NCT03995784
- Sponsor
- Catalyst Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2020-02-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.